• Lutte contre les cancers

  • Qualité de vie, soins de support

Late morbidity leading to hospitalization among 5-year survivors of young adult cancer: A report of the childhood, adolescent and young adult cancer survivors research program

A partir des données du registre de Colombie britannique portant sur 902 survivants et 9 020 témoins, cette étude de cohorte rétrospective analyse le risque de morbidités tardives entraînant une hospitalisation de survivants à cinq ans d'un cancer survenu pendant l'enfance, l'adolescence ou le début de l'âge adulte

To estimate the risk of late morbidity leading to hospitalization among young adult cancer 5-year survivors compared to the general population and to examine the long-term effects of demographic and disease-related factors on late morbidity, a retrospective cohort of 902 five-year survivors of young adult cancer diagnosed between 1981 and 1999 was identified from British Columbia (BC) Cancer Registry. A matched comparison group (N = 9020) was randomly selected from the provincial health insurance plan. All hospitalizations until the end of 2006 were determined from the BC health insurance plan hospitalization records. The Poisson regression model was used to estimate the rate ratios for late morbidity leading to hospitalization except pregnancy after adjusting for sociodemographic and clinical risk factors. Overall, 455 (50.4%) survivors and 3,419 (37.9%) individuals in the comparison group had at least one type of late morbidity leading to hospitalization. The adjusted risk of this morbidity for survivors was 1.4 times higher than for the comparison group (95% CI = 1.22–1.54). The highest risks were found for hospitalization due to blood disease (RR = 4.2; 95% CI = 1.98–8.78) and neoplasm (RR = 4.3; 95% CI = 3.41–5.33). Survivors with three treatment modalities had three-fold higher risk of having any type of late morbidity (RR = 3.22; 95% CI = 2.09–4.94) than the comparators. These findings emphasize that young adult cancer survivors still have high risks of a wide range of late morbidities.

International Journal of Cancer

Voir le bulletin